Global Head, Pricing and Market Access Cell Therapy

Within the AstraZeneca Cell Therapy Enterprise, our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units.

About the role

The Global Head, Pricing and Market Access plays a significant role in building and leading the global pricing, access and reimbursement strategies across multiple products within the Cell Therapy Strategy and Commercial function. Working cross-functionally within Cell Therapy and broadly with the global commercial teams in each Therapeutic Area (TA), this role is responsible for developing and executing market access and pricing strategies that secure reimbursement for AstraZeneca’s life-changing Cell Therapy medicines. The role also manages pricing and access inputs into long-range forecasts, ensures payer-related endpoints are included in early and late-stage evidence programs, and delivers global market access launch materials (e.g., Global Reimbursement Dossier, Global Payer Value Pack, Pricing Policies).

Responsibilities

• Provides strategic input to the vision and development of world-class Cell Therapies.
• Has full accountability for the successful development and execution of global price and access strategies, plans, and tactics for all products in AstraZeneca Cell Therapy.
• Works with function, commercial franchise leadership, governance committees, global project teams, and other internal partners to determine global payer (price and access) strategies, including:
  • Providing key pricing and payer inputs into Therapeutic Area Strategies, Target Product Profiles, Clinical Development Plans, and Integrated Development and Brand Plans.
  • Representing Cell Therapy in key review and decision-making committees, including Clinical Challenge and Therapeutic Area teams.
  • Ensuring all relevant pricing, value issues, and assumptions are integrated into and clearly visible in product forecasts and to Senior Executive Team (SET) for quarterly reporting and analyst calls.
• Oversees development and implementation of global pricing and reimbursement strategies and deliverables to meet payer needs for all payer archetypes and supports markets to implement global price and reimbursement strategies at and beyond launch.
• Responsible for the development and maintenance of a robust company understanding of relevant pricing and reimbursement needs required by payers in key markets for assessment of products:
  • Stays abreast of pricing and reimbursement trends to maintain a fully current view of internal and external influences and their implications for all molecules/products.
  • Plays a lead role in educating other internal partners and stakeholders on evolutions, dynamics, and trends regarding payer practices for drug pricing, reimbursement, legislation, and regulations across key markets.
  • Leads external payer policy shaping to improve the payer landscape on key issues important to AstraZeneca.
• Maintains a high standard and level of knowledge and understanding regarding payer evidence requirements—scientific, clinical, and commercial developments in the specific therapeutic area(s) of assignment—as well as continuous communication and effective partnering with global and marketing company cross-functional groups.
• Advances AstraZeneca’s reputation and expertise in pricing and reimbursement planning and evidence generation by participating in appropriate external forums (e.g., special interest groups of relevant organizations).
• Delivers performance management to agreed company standards:
  • Oversees and guides development of metrics for existing and future global pricing and reimbursement strategies/activities.
  • Aligns the priorities, activities, and progress against objectives and goals across the assigned group to ensure high-quality results.
  • Ensures optimal use of group resources against time, cost, and quality allocations.
  • Delivers against budget targets.
• Ensures the AZ Global Payer Evidence and Pricing function is a great place to work:
  • Leads and/or assigns departmental projects, including assigning Payer Team leaders.
  • Participates, as appropriate, in the ongoing development and enhancement of cross-functional teams.
  • Identifies, hires, develops, and retains a high-performing/high-potential team.
  • Ensures a robust succession plan is in place for direct reports and provides input for key positions on other teams.
• Oversees Health Economic and Payer Evidence (HEPE) activities, including:
  • Provides leadership and strategic direction to the development of a world-class HEPE capability.
  • Manages the recruitment and allocation of appropriately skilled HEPE personnel to projects to ensure delivery of value evidence to clinical programs (including both trial and non-trial activities) to time, budget, and quality in accordance with performance targets.
  • Works closely with the Oncology IVS and Evidence Head and appropriate clinical, real-world evidence (RWE), and patient-reported outcomes functions.

Requirements

• Proven track record of shaping and implementing value-adding Pricing & Market Access strategies globally.
• Extensive experience in leadership roles, including market access, commercial, government affairs, or medical.
• Strong experience in Pricing and Market Access within the Pharmaceutical Industry, ideally with significant experience in strategic management of stakeholders in Governments, Reimbursement Agencies, and Patient Organizations.
• Track record of successful in-market price negotiations across key markets.
• Above-market (global/regional) leadership experience.
• Commercial and/or development leadership of pre-launch and launch activities.
• Proven track record of linking science and evidence generation to drive patient access through several payer archetypes.
• Proven track record of attracting and developing talent and optimizing team performance in direct and matrixed leadership roles.

Skills

• Excellent knowledge of pricing & reimbursement (P&R) landscape and HTA systems worldwide, with a clear capability of identifying, addressing, and shaping business-critical trends.
• Exceptional written and verbal communication skills, as well as the ability to influence the external environment.
• Outstanding technical skills to shape P&MA strategies (e.g., HE modeling, RCT interpretation, evidence generation, pricing).
• Sound understanding of R&D processes and ability to articulate payer-related requirements in product development.
• Scientific mindset and deep knowledge of the pharmaceutical industry.
• Exceptional strategic thinking, judgment, and influencing skills to ensure strong commercial focus and consistency.
• Strong leadership—able to articulate a vision, set direction, and inspire commitment for own organization and broader TA group.
• Credible with R&D and Commercial leaders as well as Market Company (MC) stakeholders.
• Able to express complex ideas and strategies in clear and compelling ways to multiple stakeholder groups.
• Strong financial acumen with the ability to assess and drive portfolio value.
• Global mindset, with expertise in developing cross-functional operating models to deliver activities.

Pay

The annual base pay for this position ranges from $272,762 to $409,142. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, this position offers a short-term incentive bonus opportunity, eligibility to participate in an equity-based long-term incentive program (for salaried roles), and retirement contributions (for hourly roles).

Benefits

• Qualified retirement program (401(k) plan).
• Paid vacation and holidays.
• Paid leaves.
• Health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans.

Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment.